Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
selinexor exportin-1 small molecule Clinical trial target TTD , drugbank , DGIDB Multiple Myeloma[MeSHID:D009101]
Disease[MeSHID:D004194]
Relapse[MeSHID:D012008]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Leukemia
Myelocytic
Acute[MeSHID:D015470]
liposarcoma[MeSHID:D008080]
Carcinoma
Neuroendocrine[MeSHID:D018278]
Diffuse Large B-Cell Lymphoma[MeSHID:D016403]
Malignant Neoplasms[MeSHID:D009369]
Recurrence (disease attribute)[MeSHID:D012008]
Glioblastoma[MeSHID:D005909]		 36.37 approved,investigational,phase 3 inhibitor
selinexor exportin-1 small molecule Clinical trial target TTD , drugbank , DGIDB Multiple Myeloma[MeSHID:D009101]
Disease[MeSHID:D004194]
Relapse[MeSHID:D012008]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]		 36.37 approved,investigational,phase 3 inhibitor
click here to return to the previous page